Catalyst Wire Dossier Catalyst Wire Dossier

ELU42 topical spray

ELU42 · Eluciderm Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELU42 topical spray, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers [Phase 1, Phase 2]

See pricing